Annual report pursuant to Section 13 and 15(d)

Accrued Expenses

v3.23.1
Accrued Expenses
12 Months Ended
Dec. 31, 2022
Payables And Accruals [Abstract]  
Accrued Expenses

3. ACCRUED EXPENSES

As of December 31, 2022 and 2021, accrued expenses consisted of the following:

 

 

 

December 31,

 

 

December 31,

 

 

 

2022

 

 

2021

 

Bonus

 

$

1,094,582

 

 

$

384,750

 

Professional fees

 

 

332,589

 

 

 

380,277

 

Research and development costs

 

 

516,961

 

 

 

268,140

 

Deferred compensation to former officers

 

 

 

 

 

111,271

 

Other

 

 

159,269

 

 

 

41,157

 

Total accrued expenses

 

$

2,103,401

 

 

$

1,185,595

 

 

Deferred Compensation Agreements

As of December 31, 2022 and December 31, 2021, the Company had $0 and $111,271, respectively, of deferred compensation due to certain employees and officers of the Company pursuant to deferred compensation agreements executed during fiscal 2020 and 2019 as part of a non-qualified deferred compensation plan. Pursuant to the deferred compensation agreements, the employees had deferred a portion of their annual base salary to be paid upon a Qualified Fund Raising. The Qualified Fund Raising was achieved during July 2021. Upon this event, the employees' salaries were increased up to the market rates set forth in their respective agreements, and all amounts were paid to the employees. The remaining deferred compensation balance as of December 31, 202l relates to amounts incurred for employees who were no longer with the Company as of the payout date. During the year ended December 31, 2021, the Company accrued $193,379 in deferred compensation. The Company paid $457,749 in cash and issued 268,769 options with a total fair value of $296,264 during the year ended December 31, 2021, to settle a portion of the deferred compensation balance totaling $743,167. The fair value of the options issued in excess of the deferred compensation balance settled totaling $10,846 was recorded as stock-based compensation expense which is presented within general and administrative expenses on the statement of operations for the year ended December 31, 2021.

Accrued Bonus

During the year ended December 31, 2022 and 2021, the Company accrued $1,094,582 and $384,750, respectively, in bonus expense relating to employees and officers of the Company. On April 16, 2021, the 2020 accrued bonus balance was settled by issuance of 713,536 stock options with a total fair value of $786,531. The fair value of the options issued in excess of the accrued bonus balance totaled $6,531 and was recorded as stock-based compensation expense which is presented within general and administrative expenses on the statement of operations for the year ended December 31, 2021. The 2021 accrued bonus was paid in cash in August of 2022.